![Obi Greenman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Obi Greenman
Chief Executive Officer at CERUS CORPORATION
Net worth: 5 M $ as of 2024-06-29
Profile
Mr. William M.
Greenman is a President, Chief Executive Officer & Director at Cerus Corp.
He is on the Board of Directors at Cerus Corp.
Mr. Greenman was previously employed as an Independent Director by Aduro BioTech, Inc., an Independent Director by Chinook Therapeutics, Inc., and a Senior Vice President-Biotech Division by Baxter International, Inc. He received his undergraduate degree from Stanford University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CERUS CORPORATION
1.62% | 2024-03-31 | 2,989,614 ( 1.62% ) | 5 M $ | 2024-06-29 |
Obi Greenman active positions
Companies | Position | Start |
---|---|---|
CERUS CORPORATION | Chief Executive Officer | 2011-04-20 |
Former positions of Obi Greenman
Companies | Position | End |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Director/Board Member | 2023-08-10 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 1994-12-31 |
CHINOOK THERAPEUTICS, INC. | Director/Board Member | - |
Training of Obi Greenman
Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CERUS CORPORATION | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Private companies | 2 |
---|---|
Aduro BioTech, Inc.
![]() Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
![]() Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Obi Greenman